Immunoglobulin kappa (Ig κ) light chains are integral components of the adaptive immune system's arsenal. They are one of two types of light chains present in antibodies, the other being lambda (Ig λ) chains. Every B-cell receptor and antibody contains a pair of light chains which help define the specificity and affinity of the antibody for its unique antigen. The synthesis of Ig κ light chains is a tightly regulated process within B-cells, one that is essential for the proper functioning of the immune response. The expression of Ig κ chains can be affected by various signals that B-cells encounter in their microenvironment. These signals can originate from pathogens, cellular stress, or even from the host's own cells, acting as cues that modulate the immune response. When B-cells are activated by such signals, the rate of transcription and translation of immunoglobulin genes, including those encoding Ig κ chains, can be substantially altered. This dynamic process ensures that the immune system can adapt its antibody repertoire to effectively neutralize and clear a wide array of potential threats.
The induction of Ig κ chain expression can be stimulated by specific chemical compounds, which are recognized by the immune system as part of its sophisticated network of checks and balances. For instance, lipopolysaccharides (LPS), components of the outer membrane of Gram-negative bacteria, are potent activators of B-cells and can lead to the upregulation of Ig κ chain synthesis. This response forms part of the body's natural defense mechanism, ramping up the production of specific antibodies in the presence of bacterial invaders. Another example is the compound Phorbol 12-myristate 13-acetate (PMA), which mimics diacylglycerol, a secondary messenger that activates protein kinase C (PKC) pathways. PKC plays a pivotal role in signal transduction for various cellular processes, including the proliferation and differentiation of B-cells, which, in turn, can stimulate an increase in Ig κ chain production. Furthermore, synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG ODNs), which mimic bacterial DNA, can also induce the expression of Ig κ chains by activating Toll-like receptor 9 (TLR9) on B-cells. This activation prompts the B-cells to proliferate and differentiate, thereby enhancing the immune system's capability to produce antibodies tailored to specific pathogens. These chemical activators function as part of a complex interplay of signals that finely tune the immune response, ensuring a swift and appropriate production of antibodies, including those with Ig κ light chains, to maintain homeostasis and defend against infections.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS is a potent B-cell activator and can upregulate Ig κ expression as it simulates an immune challenge by mimicking a bacterial infection. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, as an activator of PKC, can stimulate B-cell proliferation, which may lead to an increase in Ig κ synthesis as part of the adaptive immune response. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R-848, a TLR7 and TLR8 agonist, can stimulate innate immune cells and may indirectly enhance Ig κ expression by activating the adaptive immune system. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod acts on TLR7, leading to immune cell activation. This heightened immune alertness can result in the stimulation of B-cell activity and a potential increase in Ig κ expression. | ||||||